VDPHL01: The Oral Minoxidil Pill That Just Beat Topical in Trials
VDPHL01, an oral minoxidil formulation built specifically for hair loss, showed positive Phase 2/3 results in April 2026, with data positioning it as outperforming topical minoxidil on certain measures — a genuinely notable pipeline development for anyone tired of daily scalp application.
Topical minoxidil has been the standard for decades. VDPHL01 represents something different: an oral formulation designed and dosed specifically for hair loss from the ground up, rather than a repurposed use of an existing drug.
Why "designed for hair loss" matters
Oral minoxidil has been used off-label for hair loss for years, but it was originally developed and approved as a blood pressure medication — its hair growth effect was a side effect dermatologists began prescribing off-label at lower doses. VDPHL01 is different: it's specifically formulated and dosed for hair loss, not adapted from a cardiovascular indication.
What the April 2026 trial data showed
Phase 2/3 results reported in April 2026 showed positive efficacy outcomes, with the data specifically positioning VDPHL01 as outperforming topical minoxidil on certain measures — a notable claim given topical minoxidil's decades-long status as a first-line, FDA-approved standard.
Why this could matter for daily application fatigue
One of the most common reasons people fall off a minoxidil routine is the twice-daily topical application requirement — it's a genuine behavioral burden over months and years. An effective oral option removes that specific friction point entirely, which could meaningfully improve long-term adherence for people who struggle with consistent topical application.
How this compares to existing off-label oral minoxidil
Low-dose oral minoxidil is already prescribed off-label today, covered in more detail elsewhere on this site. VDPHL01's distinction is that it's purpose-built and specifically studied for this application, rather than an adapted use of the existing blood-pressure formulation — potentially offering a more optimized dosing and delivery profile specifically for hair loss.
What to actually do with this news right now
VDPHL01 isn't broadly available yet — this is pipeline news, not a treatment you can start today. If daily topical application has been your biggest barrier to consistent minoxidil use, existing off-label oral minoxidil (already available through several telehealth providers) offers a similar no-topical-application approach today, while you watch for VDPHL01's eventual market arrival.
Strut Health From $20/month
Offers oral minoxidil prescriptions today, alongside custom topical compounds, while VDPHL01 continues through the approval pipeline.
Free Consultation →Paid linkThe bottom line
VDPHL01 represents genuine forward momentum in minoxidil formulation — a purpose-built oral option with strong early trial data. It's not available yet, but it's worth watching, and existing oral minoxidil options already offer a similar needle-and-topical-free path today.
Done With Treatments? Get a Transplant for a Fraction of US Cost.
FUE hair transplants in Colombia by board-certified surgeons. Natural, undetectable results. 3–5 hour flights from most U.S. cities. Recover in a city with perfect 75°F weather year-round.
Frequently Asked Questions
What is VDPHL01?
VDPHL01 is an oral minoxidil formulation designed and dosed specifically for hair loss, distinct from existing off-label oral minoxidil which was originally developed as a blood pressure medication.
Is VDPHL01 available now?
No — as of the April 2026 Phase 2/3 data, VDPHL01 is still in the approval pipeline and not yet broadly available. This is pipeline news to watch, not a treatment you can access today.
How does VDPHL01 compare to existing oral minoxidil?
VDPHL01 is purpose-built and specifically studied for hair loss, while existing off-label oral minoxidil is an adapted use of a blood-pressure medication, potentially giving VDPHL01 a more optimized profile specifically for this application.
Can I get oral minoxidil today while waiting for VDPHL01?
Yes — off-label oral minoxidil is already available through several telehealth providers today, offering a similar topical-application-free approach while VDPHL01 continues through its approval process.